Comments on:

Endo gets US approval for long-acting testosterone

Back to the article » |
WASHINGTON (AP) — Drugmaker Endo Pharmaceuticals announced Thursday that it received U.S. approval for its long-acting testosterone injection Aveed, which joins a crowded field of hormone-boosting drugs aimed at aging American men. The Irish drugmaker said the Food and Drug Administration approved Aveed for men with low testosterone, a condition sometimes associated with fatigue, weight gain...

To learn more about commenting on and our community guidelines, please see our comments FAQ.